跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Anzenil - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Anzenil
Approved
STANDARD
Anzenil
Yichang Humanwell Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
eeef6d8b1b85ac2c
Company
Yichang Humanwell Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
eeef6d8b1b85ac2c
Drug Approval Philippines Name
Anzenil
Product Name
Anzenil
Registration Number
DR-XY43821
Brand Name
Anzenil
Generic Name
FLUMAZENIL
Dosage Form
Solution for Intravenous Infusion
Dosage Strength
100 mcg/mL
Manufacturer
Yichang Humanwell Pharmaceutical Co., Ltd.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Company Detail Path
/organization/yichang-humanwell-pharmaceutical-co-ltd
Issuance Date
11 August 2024
Expiry Date
29 October 2029
Pharmacologic Category
Benzodiazepine-receptor Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
eeef6d8b1b85ac2c
Type
Standard
Back to Philippines FDA Approvals